Tandem Diabetes Care is a medical device company engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. Co.'s manufacturing, sales and support activities focus on Co.'s pump platform, the t:slim X2 Insulin Delivery System (t:slim X2) and its complementary product offerings. Co.'s t:slim X2 hardware platform is the commercial insulin pump that allows users to update their pumps' software from a personal computer. In addition to insulin pumps, Co. sells disposable products that are used together with its pumps, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to a user's body. The TNDM stock yearly return is shown above.
The yearly return on the TNDM stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the TNDM annual return calculation with any dividends reinvested as applicable (on ex-dates).
|